Antihypertensive Agents

"Antihypertensive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Descriptor ID	D000959
MeSH Number(s)	D27.505.954.411.162
Concept/Terms	Antihypertensive Agents Antihypertensive Agents Agents, Antihypertensive Antihypertensives Anti-Hypertensives Anti Hypertensives Antihypertensive Drugs Drugs, Antihypertensive Anti-Hypertensive Agents Agents, Anti-Hypertensive Anti Hypertensive Agents Anti-Hypertensive Drugs Anti Hypertensive Drugs Drugs, Anti-Hypertensive

Below are MeSH descriptors whose meaning is more general than "Antihypertensive Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Cardiovascular Agents [D27.505.954.411]
Antihypertensive Agents [D27.505.954.411.162]

Below are MeSH descriptors whose meaning is related to "Antihypertensive Agents".

Below are MeSH descriptors whose meaning is more specific than "Antihypertensive Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antihypertensive Agents" by people in this website by year, and whether "Antihypertensive Agents" was a major or minor topic of these publications.

Bar chart showing 149 publications over 28 distinct years, with a maximum of 12 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	1	2
1997	1	0	1
1998	0	2	2
1999	1	0	1
2001	0	1	1
2002	1	1	2
2003	4	1	5
2004	4	1	5
2005	1	0	1
2006	4	1	5
2007	5	4	9
2008	3	0	3
2009	3	0	3
2010	5	6	11
2011	1	4	5
2012	2	3	5
2013	2	2	4
2014	5	6	11
2015	10	2	12
2016	3	3	6
2017	6	4	10
2018	2	1	3
2019	5	2	7
2020	5	4	9
2021	4	3	7
2022	2	6	8
2023	3	3	6
2024	2	3	5

Below are the most recent publications written about "Antihypertensive Agents" by people in Profiles.

Smith A, Tucker KL, Barnes RK, Drakesmith CW, Agwunobi A, Bateman PA, Forbes A, de Lusignan S, Ford GA, Fujiwara T, Hobbs FDR, Koshiaris C, Mant J, McKinstry B, Pollock S, Rice C, Yang Y, McManus RJ. A service evaluation of the implementation of a novel digital intervention for hypertension self-monitoring and management system in primary care (SHIP): protocol for a mixed methods study. BMC Cardiovasc Disord. 2024 Dec 19; 24(1):707.

View in: PubMed
Mansoor T, Farrukh F, Khalid SN, Abramov D, Michos ED, Mehta A, Paul TK, Dani SS, Al Rifai M, Misra A, Nambi V, Virani SS, Minhas AMK. The future of hypertension pharmacotherapy: Ongoing and future clinical trials for hypertension. Curr Probl Cardiol. 2025 Jan; 50(1):102922.

View in: PubMed
Haring B, Andrews CA, Hovey K, Shadyab AH, LaCroix A, Martin LW, Rosal MC, Kuller LH, Salmoirago-Blotcher E, Saquib N, Koo P, Laddu D, Stefanick ML, Manson JE, Wassertheil-Smoller S, LaMonte MJ. Systolic Blood Pressure and Survival to Very Old Age: Results From the Women's Health Initiative. Circulation. 2024 May 14; 149(20):1568-1577.

View in: PubMed
Bakris GL, Saxena M, Gupta A, Chalhoub F, Lee J, Stiglitz D, Makarova N, Goyal N, Guo W, Zappe D, Desai AS. RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial. JAMA. 2024 03 05; 331(9):740-749.

View in: PubMed
Harding CC, Goldstein KM, Goldstein SA, Wheeler SM, Mitchell NS, Copeland LA. Maternal chronic hypertension in women veterans. Health Serv Res. 2024 04; 59(2):e14277.

View in: PubMed
Kitt J, Fox R, Frost A, Shanyinde M, Tucker K, Bateman PA, Suriano K, Kenworthy Y, McCourt A, Woodward W, Lapidaire W, Lacharie M, Santos M, Roman C, Mackillop L, Delles C, Thilaganathan B, Chappell LC, Lewandowski AJ, McManus RJ, Leeson P. Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management: The POP-HT Randomized Clinical Trial. JAMA. 2023 11 28; 330(20):1991-1999.

View in: PubMed
Kitt J, Krasner S, Barr L, Frost A, Tucker K, Bateman PA, Suriano K, Kenworthy Y, Lapidaire W, Lacharie M, Mills R, Roman C, Mackillop L, Cairns A, Aye C, Ferreira V, Piechnik S, Lukaschuk E, Thilaganathan B, Chappell LC, Lewandowski AJ, McManus RJ, Leeson P. Cardiac Remodeling After Hypertensive Pregnancy Following Physician-Optimized Blood Pressure Self-Management: The POP-HT Randomized Clinical Trial Imaging Substudy. Circulation. 2024 02 13; 149(7):529-541.

View in: PubMed
Nath S, Jiang T, Barrow J, Simon L. Treatment deferral for elevated blood pressure at a dental school clinic. J Dent Educ. 2024 Jan; 88(1):51-55.

View in: PubMed
Desai AS, Webb DJ, Taubel J, Casey S, Cheng Y, Robbie GJ, Foster D, Huang SA, Rhyee S, Sweetser MT, Bakris GL. Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension. N Engl J Med. 2023 Jul 20; 389(3):228-238.

View in: PubMed
Wilkie GL, Harrington CM. Clinical characteristics and subsequent need for anti-hypertensive agents in the postpartum period for hypertensive disorders of pregnancy. Pregnancy Hypertens. 2023 Jun; 32:18-21.

View in: PubMed

People

Explore

Similar Concepts

Top Journals